Wu et al. revealed that LINC00662 in the ceRNA network (the LINC00662/miR-107/HMGB1 axis) regulated cell proliferation and the invasion of glioma and could serve as a therapeutic target for patients with glioma (Wu et al., 2020). The gene discussed is HMGB1; the disease is central nervous system cancer.